Electronic health record-enabled routine assessment of medication adherence after solid organ transplantation: the time is now
- PMID: 38266711
- PMCID: PMC11846656
- DOI: 10.1016/j.ajt.2024.01.023
Electronic health record-enabled routine assessment of medication adherence after solid organ transplantation: the time is now
Abstract
Medication nonadherence after solid organ transplantation is recognized as an important impediment to long-term graft survival. Yet, assessment of adherence is often not part of routine care. In this Personal Viewpoint, we call for the transplant community to consider implementing a systematic process to screen and assess medication adherence. We believe acceptable tools are available to support integrating adherence assessments into the electronic health record. Creating a standard assessment can be done efficiently and cost-effectively if we come together as a community. More importantly, such monitoring can improve outcomes and strengthen provider-patient relationships. We further discuss the practical challenges and potential rebuttals to our position.
Keywords: adherence; electronic health record; maintenance immunosuppression.
Copyright © 2024 American Society of Transplantation & American Society of Transplant Surgeons. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplant-ation.
References
-
- Neuberger JM, Bechstein WO, Kuypers DRJ, et al. Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) group. Transplantation. 2017;101(4S): S1–S56. 10.1097/TP.0000000000001651. suppl 2. - DOI - PubMed
-
- Patel SJ, Hofmeyer BA, Moore CA, et al. Medication nonadherence monitoring and management in adult kidney transplantation: a survey of practices and perceptions at US-based transplant programs. J Am Coll Clin Pharm. 2021;4(9):1100–1108. 10.1002/jac5.1477. - DOI
-
- De Geest S, Burkhalter H, Bogert L, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. Transpl Int. 2014;27(7):657–666. 10.1111/tri.12312. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous